TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
ก.พ. 23, 2026
2 min read
20

The stock market experienced significant volatility on Monday, with major companies moving in opposite directions based on corporate news and sector-wide trends. Mega-cap technology and financial stocks, including Tesla and Oracle, saw notable declines, while the healthcare sector showed strength, led by Eli Lilly and Arcellx.
Financial giants like American Express (-7.87%) and JP Morgan Chase (-4.41%) faced downturns. The technology sector also experienced a sell-off, with Oracle Corp. dropping 5.65% and software company MongoDB falling sharply by 12.22%. In contrast, the pharmaceutical sector posted strong results. Eli Lilly (LLY) rose 4.1% after receiving FDA approval for its Zepbound KwikPen. The most significant gainer was Arcellx (ACLX), which skyrocketed 77.44% on news of its acquisition by Gilead.
Monday's trading activity highlights a market driven by company-specific catalysts rather than a single macroeconomic trend. Positive developments such as FDA approvals and acquisitions created substantial value for healthcare investors. Meanwhile, negative sentiment impacted the tech and finance sectors. The most dramatic drop was seen in small-cap Gossamer Bio (GOSS), which plunged over 84% after its primary drug trial failed to meet its endpoint.
The market's mixed performance underscores the importance of individual company fundamentals. Investors are closely reacting to specific news events, leading to significant divergence between sectors. Future market direction will likely depend on continued corporate earnings reports and sector-specific developments.
Q: Which company saw the largest gain on Monday?
A: Arcellx (ACLX) was the top performer, with its stock increasing by 77.44% following the announcement of its acquisition by Gilead.
Q: Why did Eli Lilly's stock price increase?
A: Eli Lilly's stock rose 4.1% after the company gained FDA approval for its Zepbound multi-dose KwikPen device for weight loss.
Q: Which major tech stocks declined?
A: Several major tech and software stocks fell, including Oracle (-5.65%), MongoDB (-12.22%), and Datadog (-11.69%).
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles

24 ก.พ. 2026
Paramount Ups Bid for Warner Bros. Discovery

24 ก.พ. 2026
FedEx Sues US Government for Trump Tariff Refund

24 ก.พ. 2026
FedEx Sues US Government for Tariff Refunds